SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-06-001030
Filing Date
2006-03-06
Accepted
2006-03-06 15:54:28
Documents
10
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K w18029e10vk.htm 10-K 710250
2 EXHIBIT 10.33 w18029exv10w33.htm EX-10.33 150012
3 EXHIBIT 10.34 w18029exv10w34.htm EX-10.34 133191
4 EXHIBIT 21 w18029exv21.htm EX-21 656
5 EXHIBIT 23 w18029exv23.htm EX-23 5513
6 EXHIBIT 31.1 w18029exv31w1.htm EX-31.1 8451
7 EXHIBIT 31.2 w18029exv31w2.htm EX-31.2 8455
8 EXHIBIT 32.1 w18029exv32w1.htm EX-32.1 4150
9 EXHIBIT 32.2 w18029exv32w2.htm EX-32.2 4168
10 GRAPHIC w18029w1802901.gif GRAPHIC 15191
  Complete submission text file 0000950133-06-001030.txt   1047304
Mailing Address 508 LAPP ROAD MALVERN PA 19355
Business Address 508 LAPP ROAD MALVERN PA 19355 4849131200
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26770 | Film No.: 06667292
SIC: 2836 Biological Products, (No Diagnostic Substances)